Clinical Observation on Xuezhikang Capsule for 116 Cases of Coronary Heart Disease with Abnormal Blood Lipid
- VernacularTitle:血脂康胶囊治疗冠心病血脂异常患者116例临床观察
- Author:
Ke ZHOU
;
Banghan DING
- Publication Type:Journal Article
- Keywords:
Xuezhikang Capsule;
Regulation of blood lipid;
Differentiation of phlegm syndromes;
Coronary heart disease (CHD);
Abnormal blood lipid
- From:
Journal of Traditional Chinese Medicine
1992;0(11):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the different effect of Xuezhikang Capsule on the patients of coronary heart disease (CHD) with abnormal blood lipid in different syndromes.Methods Of the 116 patients of CHD with abnormal blood lipid diagnosed by coronary arteriography and blood test, 30 were blood stasis syndrome, 23 phlegm turbid syndrome, 26 phlegm retention syndrome, and 37 non-phlegm non-stasis syndrome. Based on the standard treatment with modern medicine, Xuezhikang Capsule was given 0.6g each time, twice a day, for 24 weeks in succession.Results After the treatment, total cholesterol (TC), triglyceride (TG) and low density lipoprotein-C (LDL-C) were decreased (P
